Presentation and practical management to optimize radioiodine treatment of well differentiated thyroid cancer: ablation of thyroid remnants with radioiodine.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to H J Altenbrunn.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The authors report about investigations for localization of tumours in vivo by scintigrafic iddntification of Clostridium butyricum Jena H8 by 131I-labelled antibodies and by 131I-labelled F(ab')2-fragment antibodies in mouse transplantation-tumour UVT 15264. The application of 131I-labelled anti-clostridial-rod-antibodies in tumour bearing mice demonstrates increase of radioactivity in tumours of animals, pretreated by spores, as well as in animals without pretreatment. These appearently unspecific increases of radioactivity could not be demonstrated by application of 131I-labelled F(ab')2-fragment antibodies directed against clostridial rods, but also the specific fixation of 131I-labelled F(ab')2-fragment antibodies in tumours of mice, pretreated by clostridial spores, could not be demonstrated. The results are discussed with regard to further investigations.
A survey is given on the modern possibilities of the therapy of malignant tumours with radiopharmaca. In detail the following methods of treatment introduced into the nuclearmedical therapy are described: 1. Radioiodine therapy in folliculary and papillary carcinomas of the thyroid gland, 2. Radiophosphorus therapy in polycythaemia vera and myeloproliferative syndrome, 3. Radiogold therapy in peritoneal and pleural carcinoses, 4. Intrathecal radionuclide application in meningeosis leucaemica, 5. Intralymphatic radionuclide application to the therapy of malignant lymphomas, 6. Radionuclide therapy of multiple bone metastases. With the help of literature and own experiences the author enters the indication and the performance of the therapy as well as the possible successes of treatment, when using the therapy forms mentioned.
After introductory comments on the principle of the tumour scintigraphy and the factors influencing the scintigraphic demonstration the author adopts a definite attitude to the scintigraphy of thyroid gland, brain, lung, liver pancreas, kidney, bone, spleen as well as lymphatic nodes, liquor spaces and adrenal glands from the point of view of tumours diagnostics. For the purpose of a better survey for the first seven organs uniquely the problems are demonstrated according to the principle of examination, method of examination, indication to the tumour diagnostics, preliminary examination and prerequisite to the scintigraphy, the problems of scintigraphy and the functional capacity of other methods.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.